Swedish Krona May Gain as Geopolitical Tensions Ease
ING sees modest upside for the Swedish krona if French fiscal risks continue to weigh on the euro for longer.
EUR/SEKSwedish kronaEuro
1 source · Dow Jones Newswires
market news
energy, macro and geopolitical news for traders, with market context and links to the original sources.
stories appear here with a 15-minute delay. in real time — via the api connect the api →
1988 stories · page 56 / 100
Needham reaffirms Buy rating on Harmony Biosciences, $50 target
Needham maintained its Buy rating and $50 price target for Harmony Biosciences, implying 24.1% upside from the stock’s Oct. 9 close.
Harmony Biosciences Hldgs
2 sources · Newsmetry API, TradingView
Frasers lifts Burberry stake to 7.42% as luxury push continues
British retailer Frasers has increased its Burberry holding again while expanding its strategy and interests in the luxury sector.
BurberryFrasersHugo Boss
1 source · Reuters
Citizens Lowers Price Targets for Stewart and Brown & Brown
Citizens cut its price targets for Stewart Info Services and Brown & Brown, while keeping Brown & Brown at Market Outperform.
STCBRO
2 sources · Dow Jones Newswires
High oil prices and strong fundamentals support Norwegian krone
ING says the Norwegian krone may strengthen further as elevated oil prices and supportive fundamentals outweigh weaker liquidity conditions.
Norwegian kroneEUR/NOKBrent
1 source · Dow Jones Newswires
Siemens Energy Repurchases 936,589 Shares on Oct. 5–11
Siemens Energy bought back 936,589 shares under its repurchase program, taking cumulative purchases since Sept. 24 to 2,122,004 shares.
Siemens Energy AGENR
2 sources · TradingView
Siemens Energy reports weekly share-buyback figures
Siemens Energy bought 936,589 shares from October 5 to 11, bringing purchases since the program began to 2,122,004 shares.
Siemens Energy AGDE000ENER6Y0
1 source · pressetext
Xi’s ambitions deepen China’s debt burden and trade pressure abroad
Dow Jones Newswires, citing the WSJ, reports that China’s nonfinancial-sector credit exceeded 300% of GDP as debt-fueled overcapacity spread overseas.
CNYChinese equitiesChina government bondsEUR/USDBrent
1 source · Dow Jones Newswires
Deutsche Bank upgrades AST SpaceMobile stock to Buy
Deutsche Bank analyst Bryan Kraft called AST SpaceMobile’s recent decline misguided and raised the stock rating to Buy, keeping the target at $93.
AST SpaceMobileSpaceXRocket LabT-MobileAT&TS&P 500
1 source · Dow Jones Newswires
Starbucks Denies Reports That It Plans to Buy Chipotle
Starbucks said it will not acquire Chipotle after reports that the burrito chain had discussed a possible proposal with advisers.
StarbucksChipotle Mexican Grill
1 source · Dow Jones Newswires
Italy’s advertising spending rose 1% year on year in August
Nielsen reported that advertising spending in Italy increased 1% year on year in August, Reuters said.
1 source · Reuters
Microsoft plans to introduce Maia 300 AI chip in 2027
Microsoft says its next AI accelerator will target inference, boosting token throughput and power efficiency across the company’s cloud-scale systems.
MicrosoftTaiwan Semiconductor Manufacturing CoNvidia
1 source · Seeking Alpha
U.S. Natural Gas Futures Retreat as Weather Demand Fades
U.S. natural gas futures fell after Friday’s rise as warmer forecasts curbed demand, while offshore production continued recovering from Hurricane Isaias.
Nymex natural gasHenry Hub natural gas
2 sources · Dow Jones Newswires, Newsmetry API
Schroder Euro Real sets sterling dividend at 1.24986 pence
London Stock Exchange said Schroder European Real Estate Investment Trust will pay UK-register holders 1.24986 pence per share in sterling.
Schroder European Real Estate Investment Trust plcGBPEURJSE Limited
1 source · London Stock Exchange
UBS Initiates Ocular Therapeutix Coverage With Buy Rating
UBS began covering Ocular Therapeutix with a Buy rating and set a $14.00 per-share price target for the company’s stock.
OCUL
1 source · Dow Jones Newswires
Guggenheim Raises Elevance Health Price Target to $460
Guggenheim increased its price target for Elevance Health to $460 per share from $455, according to ratings data from Benzinga.
ELVElevance Health
1 source · Dow Jones Newswires
Guggenheim Maintains Buy Rating on Everpure
Guggenheim kept its Buy rating on Everpure, according to Benzinga’s summary of analyst rating actions.
Everpure
1 source · Dow Jones Newswires
KBW Keeps Outperform Ratings on Chubb and Goosehead
Keefe, Bruyette & Woods maintained its Outperform rating on Chubb Ltd and Goosehead Insurance, according to analyst actions published by Benzinga.
CBGSHD
2 sources · Dow Jones Newswires, Newsmetry API
UBS Starts AbCellera Biologics Coverage With Buy Rating
UBS began covering AbCellera Biologics with a Buy rating and set a target price of $18.00 per share, according to a Benzinga ratings update.
ABCLAbCellera Biologics
1 source · Dow Jones Newswires
HCLTech says lower software sales weighed on second-quarter growth
HCLTech said weaker software product sales affected second-quarter growth, while demand remained healthy toward the quarter’s end amid a fluid environment.
HCLTech
1 source · Reuters